MENU
component-ddb-728x90-v1-01-desktop

Study gives Alzheimer's patients hope for treatment

Dr. Alvin Lin, medical director at Aegis Living in Las Vegas, says a clinical trial gives hope to Alzheimer's sufferers that supports a theory that the buildup of protein is the cause of Alzheimer's. "At least we have something that supports a theory and we also have some improvement." He spoke to News 3 on Saturday, Sept. 3, 2016. (George Romero/KSNV)

A landmark study from the company Biogen has given new hope to the 5 million Alzheimer’s sufferers in America.

The company completed human trials of a drug designed to break down the Amyloid protein that builds up in Alzheimer’s sufferers' brains.

Researchers theorize that the buildup of the protein is the cause of Alzheimer’s.

The human trials of 165 patients showed that increased doses had a positive effect on symptoms. Researchers will not call it a cure, but it has renewed hopes that treatment could be on its way.

“They did x-rays and imaging to show that there was improvement in the brain, and they were also able to demonstrate by some measure that there was some improvement in their thinking process,” said Dr. Alvin Lin, medical director of Aegis Living in Las Vegas. He went on to say that while it was a small sample size but, “at least we have something that supports a theory and we also have some improvement.”

Residents of Aegis Living held an end of summer celebration on Saturday.

Trending